Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study.
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Abdominal pain; Cancer pain
- Focus Therapeutic Use
- Acronyms PANPAIN1
- 04 Oct 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
- 04 Oct 2017 Status changed from recruiting to discontinued.
- 30 Sep 2016 Results of preliminary analysis assessing efficacy, presented at the 16th World Congress on Pain